Female libido drug advances to clinical trials; StemCells launches Alzheimer's program;

@FierceBiotech: PR: Adocia, Eli Lilly end collaboration; Adocia reacquires exclusive development rights to insulin analog. Release | Follow @FierceBiotech

@RyanMFierce: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement. Item | Follow @RyanMFierce

@EmilyMFierce: Novavax joins H7N9 vaccine race, reports positive preclinical data. Article | Follow @EmilyMFierce

> Catabasis Pharmaceuticals reports that in a Phase I trial of CAT-2003 significantly reduced fasting and postprandial triglyceride levels as well as lowered plasma PCSK9 levels and LDL cholesterol. Release

> StemCells ($STEM) has formally launched its Alzheimer's disease program, which is being supported by the California Institute for Regenerative Medicine (CIRM). Release

> Cambridge, MA-based Sialix has closed a $1 million round of an angel-led financing. More

Medical Device News

@FierceMedDev: Intuitive doubles stock buyback to quell investor angst. Article | Follow @FierceMedDev

@MarkHFierce: Haemonetics lost money in FY 2014 Q1 - Manufacturing reorg and M&A costs contributed. Yesterday's story | Follow @MarkHFierce

@DamianFierce: In case you missed it last night: GE Healthcare is recalling scanners after patient crushed to death in U.S. Report | Follow @DamianFierce

 @MichaelGFierce: NeuroSigma to begin PhIII epilepsy device trial. ICYMI yesterday | Follow @MichaelGFierce

> Roche, Thermo unite for sepsis diagnostics. Article

> Foundation Medicine pursues $86.3M IPO. Story

> FDA's first-time PMAs down drastically so far in 2013. Item

Pharma News

@FiercePharma: ICYMI: Pfizer to split operations three ways. Yesterday's story | Follow @FiercePharma

@CarlyHFierce: India's Cadila Pharma selects site for $150M plant in Russia. Article | Follow @CarlyHFierce

> Suffering from generic onslaught, Merck cuts sales forecast. Story

> Sanofi's bid for more OTC meds gets FDA boost. Article

> Moody's cuts GlaxoSmithKline outlook, citing billions in outlays. Report

Biotech Research News

@EmilyMFierce: UCLA team IDs anti-amyloid compounds to treat Alzheimer's, other brain diseases. Story | Follow @EmilyMFierce

> Novavax joins H7N9 vaccine race, reports positive preclinical data. News

> Antibody effective at fighting norovirus in chimps. Story

Pharma Manufacturing News

@EricPFierce: Lawmakers want assurances Smithfield sale to China's Shuanghui won't leave US drugmakers short of heparin. Report | Follow @EricPFierce

> Cadila Pharma selects site for $150M Russian plant. News

> Alexion adding 50 jobs in Ireland to grow global supply chain. Item

> Pfizer says investments in Ireland position plants for growth. More

> New Russian company to build $85M plant. Story

> Bristol-Myers turns to Samsung for cancer drug. Article

And Finally... New Jersey-based S1 Biopharma is beginning a clinical trial of Lorexys, a new female libido drug. Story (sub. req.)